Slide 1: First-half 2021 report
First-half 2021 report Webcast for investors, analysts and media Basel, August 12, 2021 1 Disclaimer This presentation contains certain forward-looking statements that reflect the current views of management. Such statements are subject to known and unknown risks, uncertainties and other factors tha
Slide 2: Agenda / Highlights
Agenda Highlights Guillaume Daniellot Business & regional review Peter Hackel Recent achievements & strategy in action Guillaume Daniellot Outlook 2021 Guillaume Daniellot Guillaume Daniellot Q&A and upcoming events Peter Hackel 3 Highlights Guillaume Daniellot, CEO 4 2
Slide 3: Growth further accelerates in the second quarter
Growth further accelerates in the second quarter FIRST-HALF REVENUE ORGANIC GROWTH1 CORE PROFITABILITY CHF 986m +63% EBIT margin 28.8% CHF 516m revenue in Q2 +103% in Q2 IFRS EBIT margin 28.3% 60 bps currency effect in Q2 IMPLANTOLOGY ORTHODONTICS OUTLOOK2 Immediacy thriving DTC strengthened Raised
Slide 4: Business and regional review
Business and regional review Peter Hackel, CFO 7 Record half-year result Revenue development by quarter (in CHF million, rounded) 600 500 400 300 200 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 2019 2019 2019 2019 2020 2020 2020 2020 2021 2021 8 8 4
Slide 5: Strong revenue growth in the first half of 2021
Strong revenue growth in the first half of 2021 Revenue development (in CHF million, rounded) Regional share of 62.9% organic growth in CHF 63.1% organic Change in organic growth 57.0% 67.3% 68.1% 75.3% 9 9 EMEA and North America report triple-digit growth EMEA Revenue change (organic) Germany, Ib
Slide 6: Latin America and Asia Pacific show strong growth
Latin America and Asia Pacific show strong growth Asia Pacific Revenue change (organic) Increased market share led by 56% 74.4% 62.8% China, Japan and Taiwan Premium and challenger 20% of Group* 16.0% 23.4% 24.5% 17.9% implant brands drive growth, 11.0% challengers growing faster Q2 Q3 Q4 Q1 Q2
Slide 7: Core financials at a glance
Core financials at a glance % of Margin Change In CHF million, rounded H1 2021 Comments revenue change in % Revenue 985.5 100.0% 62.9% COGS (233.8) 23.7%placeholder 33.4% GROSS PROFIT 751.7 76.3% 530bps 74.9% FX headwind -30bps Operating expenses (467.7) 47.5% 41.9% EBIT 284.0 28.8% 1220bps 183.4% F
Slide 8: Overview: core results reconciliation
Overview: core results reconciliation 15 1 Other finance expense refers to an earn-out adjustment for DrSmile 15 Core gross margin above 76% In %, rounded 530bps 560bps 76.2 16 16 8
Slide 9: Core EBIT margin almost at 29%
Core EBIT margin almost at 29% In %, rounded 1220bps 1250bps 2510bps thereof = impairments 17 17 Core net profit margin improved to 23% In CHF million, rounded 1090bps thereof CHF 150m impairments Net profit Net profit margin margin 12.2% 23.1% 18 18 9
Slide 10: Historically high free cash flow
Historically high free cash flow Operating cash flow In CHF million Y/Y change In CHF million, rounded HY1 2020 60.7 HY1 2021 256.7 +423% 1940bps FCF margin FCF margin 1.9% 21.3% 19 19 Recent achievements & strategy in action Guillaume Daniellot, CEO 20 10
Slide 11: Seizing opportunities in the premium implant market
Seizing opportunities in the premium implant market Immediacy segment Parallel walled Apically tapered Fully tapered TL BL BLT BLX TLX 1986 2007 2014 2019 2021 21 Straumann share Market opportunity Source: STMN Group market model & data 2020 21 Immediacy driving growth in the premium implant busines
Slide 12: Capturing the huge potential in the value market
Capturing the huge potential in the value market PREMIUM EMEA NAM Challenger CHALLENGER Challenger Eco LATAM APAC Straumann share Market opportunity 23 Source: STMN Group market model & data 2020 23 Global presence covering all price points EMEA NAM APAC LATAM 24 24 12
Slide 13: Orthodontics business growing very significantly
Orthodontics business growing very significantly High-performance material ClearQuartz Launched worldwide except for China Software feature Collaborator Enabling doctors to collaborate on cases with their staff, other doctors and treatment planning services ClearPilot 2.0 software update Simpl
Slide 14: Investing in people to further capture opportunities
Investing in people to further capture opportunities >800 new colleagues since December 31 Headcount 8500 Mainly in: 8169 Operations 8000 supporting Neodent and implant volume growth Orthodontics 7500 DTC activity (DrSmile development) and production 7340 7273 7000 6500 6000 2020 HY 2020 FY 2021
Slide 15: Outlook 2021
Outlook 2021 29 Outlook raised Dental practices operating, healthy patient flows Market Group expects softer tailwind in the second half of the year environment Pandemic remains unpredictable Strong first-half of 2021 Our revenue Group aims to achieve organic revenue growth of above thirty
Slide 16: Questions & answers
Questions & answers & 31 Calendar of upcoming events 2021 Event Location September 1 Stifel Cross Sector Conf Virtual September 8 Roadshow Geneva September 9 Roadshow Zurich September 15 UBS Best of Switzerland Conference Virtual September 16 J.P. Morgan CEO Call Series Virtual September 17 Bank of
Slide 17: Straumann Group's currency exposure
Straumann Group’s currency exposure Revenue breakdown H1 2021 Exchange rates development Jan 2020 - Jun 2021 CHF 160 Other 1% 17% EUR 140 BRL 34% 4% 120 CNY 100 11% 80 USD/CAD/AUD 12/2019 03/2020 06/2020 09/2020 12/2020 03/2021 06/2021 33% USDCHF EURCHF CNYCHF BRLCHF Total cost breakdown H1 2021 Oth